Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020564 · ClinicalTrials.gov registry record · NA
Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment
A NA study of Mild Cognitive Impairment and Traumatic Brain Injury, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT02020564: Completed NA study of Mild Cognitive Impairment and Traumatic Brain Injury, sponsored by Kessler Foundation.
NCT02020564 is a NA study of Mild Cognitive Impairment and Traumatic Brain Injury that has completed, run by Kessler Foundation. The registered enrollment target is 80 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02020564, a NA study of Mild Cognitive Impairment and Traumatic Brain Injury, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate the effectiveness of a technique designed to improve processing speed (i.e. the amount of time it takes to process information) in a Traumatic Brain Injury (TBI) population. The study is designed to study how well this technique can help people with TBI increase their processing speed and their ability to function better in everyday life.
Primary Outcome
Change in scores on standardized neuropsychological tests of Processing Speed using Symbol-Digit Modalities Test
Conditions Studied
Interventions
- BEHAVIORAL Placebo Control
- BEHAVIORAL Speed of Processing Training
Study Locations (1)
New Jersey
- Kessler Foundation - East Hanover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-12-12 |
| Est. Completion | 2022-12-30 |
| Phase | NA |
What the finished NCT02020564 record still lists
NCT02020564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Placebo Control is the first listed.
NCT02020564 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02020564 about?
NCT02020564 is a clinical study titled "Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment". The purpose of this research study is to investigate the effectiveness of a technique designed to improve processing speed (i.e. the amount of time it takes to process information) in a Traumatic Brain Injury (TBI) population. The study is designed to study how well this technique can help people wi...
What is the current status of trial NCT02020564?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2012-12-12. Estimated completion is 2022-12-30.
What conditions does trial NCT02020564 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Traumatic Brain Injury.
What interventions are being tested in trial NCT02020564?
The interventions under investigation include: Placebo Control (BEHAVIORAL), Speed of Processing Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02020564?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02020564 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02020564's enrollment target sits among peer trials
80 104th of 205 higher than 97 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Impact of Intensive Computerized Cognitive Training
RECRUITING · NA
-
Multimodal Investigation of Neural Plasticity
RECRUITING · NA
-
GAMES Intervention in MCI (Mild Cognitive Impairment)
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI